Use of virus as therapeutic agent, other than vaccine

Industry

CPC
C12N2710/10032

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2710/00dsDNA Viruses

Current Industry

C12N2710/10032Use of virus as therapeutic agent, other than vaccine

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for treating type 1 and type 2 diabetes an...
- Patent number 12,213,999
- Issue date Feb 4, 2025
- Salk Institute for Biological Studies
- Ronald M. Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor-selective E1a and E1b mutants
- Patent number 12,195,766
- Issue date Jan 14, 2025
- The Regents of the University of California
- Tony Reid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-immunogenic protein nanoparticles with cancer targeting activit...
- Patent number 12,098,164
- Issue date Sep 24, 2024
- CELLEMEDY CO., LTD.
- Jeewon Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating solid or lymphatic tumors by combination therapy
- Patent number 12,090,183
- Issue date Sep 17, 2024
- CG ONCOLOGY, INC.
- Alex Wah Hin Yeung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PH-sensitive and bioreducible polymer-virus complex for cancer trea...
- Patent number 11,970,715
- Issue date Apr 30, 2024
- GENEMEDICINE CO., LTD.
- Chae Ok Yun
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Group B adenovirus encoding an anti-TCR-complex antibody or fragment
- Patent number 11,970,536
- Issue date Apr 30, 2024
- AKAMIS BIO LIMITED
- Brian Robert Champion
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication-enhanced oncolytic adenoviruses
- Patent number 11,951,141
- Issue date Apr 9, 2024
- MEMGEN, Inc.
- Mark J. Cantwell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activation of resident memory T cells for cancer immunotherapy
- Patent number 11,642,401
- Issue date May 9, 2023
- Regents of The University of Minnesota
- David B. Masopust
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for attenuating anti-viral transfer vector...
- Patent number 11,633,422
- Issue date Apr 25, 2023
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor-selective E1A and E1B mutants
- Patent number 11,618,888
- Issue date Apr 4, 2023
- The Regents of the University of California
- Tony Reid
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating bladder cancer
- Patent number 11,596,660
- Issue date Mar 7, 2023
- CG ONCOLOGY, INC.
- Arthur Kuan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating bladder cancer by combination therapy comprisin...
- Patent number 11,497,781
- Issue date Nov 15, 2022
- CG ONCOLOGY, INC.
- Alex Wah Hin Yeung
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic agents and uses thereof for drugs for treatment of tumo...
- Patent number 11,446,345
- Issue date Sep 20, 2022
- HANGZHOU CONVERD CO., LTD.
- Fang Hu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for removing anti-AAV antibodies from a blood-derived compos...
- Patent number 11,376,321
- Issue date Jul 5, 2022
- Genethon
- Bérangére Bertin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating bladder cancer with an oncolytic virus
- Patent number 11,338,003
- Issue date May 24, 2022
- CG ONCOLOGY, INC.
- Arthur Kuan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosing regime and formulations for type B adenovirus
- Patent number 11,173,186
- Issue date Nov 16, 2021
- PSIOXUS THERAPEUTICS LIMITED
- John William Beadle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ph-sensitive and bioreducible polymer-virus complex for cancer trea...
- Patent number 11,174,465
- Issue date Nov 16, 2021
- GENEMEDICINE CO., LTD.
- Chae Ok Yun
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Virus encoding an anti-TCR-complex antibody or fragment
- Patent number 11,155,622
- Issue date Oct 26, 2021
- PSIOXUS THERAPEUTICS LIMITED
- Alice Claire Noel Brown
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
AAV8 mutant capsids and compositions containing same
- Patent number 11,091,776
- Issue date Aug 17, 2021
- The Trustees of the University of Pennsylvania
- James M. Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oncolytic adenovirus compositions
- Patent number 11,077,156
- Issue date Aug 3, 2021
- Salk Institute for Biological Studies
- Clodagh O'Shea
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating type 1 and type 2 diabetes an...
- Patent number 10,912,800
- Issue date Feb 9, 2021
- Salk Institute for Biological Studies
- Ronald M. Evans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tumor-selective E1a and E1b mutants
- Patent number 10,876,097
- Issue date Dec 29, 2020
- Tony Reid
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Enhanced adoptive cell therapy
- Patent number 10,787,645
- Issue date Sep 29, 2020
- TILT BIOTHERAPEUTICS OY
- Akseli Hemminki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tropism modified cancer terminator virus (Ad.5/3 CTV;Ad.5/3-CTV-M7)
- Patent number 10,744,172
- Issue date Aug 18, 2020
- Virginia Commonwealth University
- Paul Fisher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activation of resident memory T cells for cancer immunotherapy
- Patent number 10,722,537
- Issue date Jul 28, 2020
- Regents of The University of Minnesota
- David B. Masopust
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Enhanced adoptive cell therapy
- Patent number 10,647,963
- Issue date May 12, 2020
- TILT BIOTHERAPEUTICS OY
- Akseli Hemminki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for modulating AAV infection
- Patent number 10,633,662
- Issue date Apr 28, 2020
- The Board of Trustees of the Leland Stanford Junior University
- Sirika Pillay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multitargeting onocolytic adenovirus, methods of use, and methods o...
- Patent number 10,617,729
- Issue date Apr 14, 2020
- The UAB Research Foundation
- George Clement Dobbins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
AAV vectors with expanded packaging capacity
- Patent number 10,406,244
- Issue date Sep 10, 2019
- The Board of Trustees of the Leland Stanford Junior University
- Mark A. Kay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MiR-204 and miR-211 and uses thereof
- Patent number 10,369,231
- Issue date Aug 6, 2019
- Fondazione Telethon
- Sandro Banfi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
METHOD FOR TREATING TUMOR WITH COMBINATION OF EXOGENOUS ANTIGEN AND...
- Publication number 20240342266
- Publication date Oct 17, 2024
- GUANGZHOU ANJIE BIOMEDICAL TECHNOLOGY CO., LTD.
- Chao Zhou
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SELECTIVE STIMULATION OF T CELLS IN SOLID TUMORS USING ONCOLYTIC VI...
- Publication number 20240299541
- Publication date Sep 12, 2024
- The Trustees of the University of Pennsylvania
- Mikko Siurala
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNOEVASIVE ANTI-TUMOR ADENOVIRUS
- Publication number 20240293487
- Publication date Sep 5, 2024
- Jin-Woo CHOI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR BONE AND SOFT TISSUE TUMORS
- Publication number 20240252561
- Publication date Aug 1, 2024
- Surv BioPharma Inc.
- Ken-ichiro KOSAI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GROUP B ADENOVIRUS ENCODING AN ANTI-TCR-COMPLEX ANTIBODY OR FRAGMENT
- Publication number 20240247061
- Publication date Jul 25, 2024
- AKAMIS BIO LIMITED
- Brian Robert CHAMPION
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ADENOVIRUS FOR TREATMENT OF CANCER
- Publication number 20240189374
- Publication date Jun 13, 2024
- ELICERA THERAPEUTICS AB
- Di YU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC BROAD-SPECTRUM ONCOLYTIC ADENOVIRUS WITH MULTIPLE MECHANIS...
- Publication number 20240165176
- Publication date May 23, 2024
- VONCOLYTIC THERAPEUTICS CO., LTD.
- Jiang LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Oncolytic Virus and Methods of Use
- Publication number 20240150792
- Publication date May 9, 2024
- Northshore University Healthsystem
- Prem Seth
- C07 - ORGANIC CHEMISTRY
Information Patent Application
An oncolytic virus vector coding for variant interleukin-2 (vIL-2)...
- Publication number 20240102047
- Publication date Mar 28, 2024
- TILT Biotherapeutics Oy
- Sadia Zafar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATE...
- Publication number 20230364222
- Publication date Nov 16, 2023
- DEVACELL, INC.
- Inanc ORTAC
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT ADENOVIRUS GENOME HAVING A SYNTHETIC TRANSCRIPTIONAL UN...
- Publication number 20230220355
- Publication date Jul 13, 2023
- Salk Institute for Biological Studies
- William Partlo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY
- Publication number 20230052537
- Publication date Feb 16, 2023
- CG Oncology, Inc.
- Alex Wah Hin YEUNG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CEL...
- Publication number 20220339220
- Publication date Oct 27, 2022
- Hangzhou Converd Co., Ltd.
- Fang HU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING BLADDER CANCER
- Publication number 20220331384
- Publication date Oct 20, 2022
- CG Oncology, Inc.
- Arthur KUAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Fast and Accurate Three-Plasmid Oncolytic Adenovirus Recombinant Pa...
- Publication number 20220235332
- Publication date Jul 28, 2022
- VONCOLYTIC THERAPEUTICS CO., LTD.
- Yinghan Su
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VECTORIZED ANTIBODIES AND USES THEREOF
- Publication number 20220106611
- Publication date Apr 7, 2022
- HOMOLOGY MEDICINES, INC.
- Carmen BARNES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ONCOLYTIC ADENOVIRUS COMPOSITIONS
- Publication number 20220096577
- Publication date Mar 31, 2022
- Salk Institute for Biological Studies
- Clodagh O'Shea
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PH-SENSITIVE AND BIOREDUCIBLE POLYMER-VIRUS COMPLEX FOR CANCER TREA...
- Publication number 20220090025
- Publication date Mar 24, 2022
- Genemedicine Co., Ltd.
- Chae Ok YUN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES
- Publication number 20220054563
- Publication date Feb 24, 2022
- PSIOXUS THERAPEUTICS LIMITED
- John Beadle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITION COMPRISING NC886 FOR IMPROVING ONCOLYTIC VIRUS ACTIVITY...
- Publication number 20220025338
- Publication date Jan 27, 2022
- NATIONAL CANCER CENTER
- Yongsun LEE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VIRUS EXPRESSING PD-1 BINDING PROTEIN AND APPLICATION OF...
- Publication number 20210403564
- Publication date Dec 30, 2021
- SHANGHAI YUANSONG BIOTECHNOLOGY CO. LTD.
- Kangjian ZHANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL AAV8 MUTANT CAPSIDS AND COMPOSITIONS CONTAINING SAME
- Publication number 20210340569
- Publication date Nov 4, 2021
- The Trustees of the University of Pennsylvania
- James M. Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TUMOR-SELECTIVE E1A AND E1B MUTANTS
- Publication number 20210171917
- Publication date Jun 10, 2021
- The Regents of the University of California
- Tony Reid
- C07 - ORGANIC CHEMISTRY
Information Patent Application
REPLICATION-ENHANCED ONCOLYTIC ADENOVIRUSES
- Publication number 20210128653
- Publication date May 6, 2021
- MEMGEN, Inc.
- Mark J. CANTWELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TROPISM MODIFIED CANCER TERMINATOR VIRUS (AD.5/3 CTV;AD.5/3-CTV-M7)
- Publication number 20200397839
- Publication date Dec 24, 2020
- Virginia Commonwealth University
- Paul B. Fisher
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Enhanced adoptive cell therapy
- Publication number 20200399615
- Publication date Dec 24, 2020
- TILT Biotherapeutics Oy
- Akseli Hemminki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Isolated Recombinant Oncolytic Adenoviruses, Pharmaceutical Composi...
- Publication number 20200276252
- Publication date Sep 3, 2020
- Hangzhou Converd Co., Ltd.
- Jipo SHENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tissue Targeted Antigenic Activation of the Immune Response to Trea...
- Publication number 20200121784
- Publication date Apr 23, 2020
- Qu Biologics Inc.
- Harold David Gunn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR REMOVING ANTI-AAV ANTIBODIES FROM A BLOOD-DERIVED COMPOS...
- Publication number 20200069790
- Publication date Mar 5, 2020
- Genethon
- BÉRANGÉRE BERTIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING...
- Publication number 20190358277
- Publication date Nov 28, 2019
- Genemedicine CO., LTD.
- Chae Ok YUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Use of virus as therapeutic agent, other than vaccine

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Compositions and methods for treating type 1 and type 2 diabetes an...

Tumor-selective E1a and E1b mutants

Non-immunogenic protein nanoparticles with cancer targeting activit...

Methods of treating solid or lymphatic tumors by combination therapy

PH-sensitive and bioreducible polymer-virus complex for cancer trea...

Group B adenovirus encoding an anti-TCR-complex antibody or fragment

Replication-enhanced oncolytic adenoviruses

Activation of resident memory T cells for cancer immunotherapy

Methods and compositions for attenuating anti-viral transfer vector...

Tumor-selective E1A and E1B mutants

Methods of treating bladder cancer

Methods of treating bladder cancer by combination therapy comprisin...

Therapeutic agents and uses thereof for drugs for treatment of tumo...

Method for removing anti-AAV antibodies from a blood-derived compos...

Methods of treating bladder cancer with an oncolytic virus

Dosing regime and formulations for type B adenovirus

Ph-sensitive and bioreducible polymer-virus complex for cancer trea...

Virus encoding an anti-TCR-complex antibody or fragment

AAV8 mutant capsids and compositions containing same

Oncolytic adenovirus compositions

Compositions and methods for treating type 1 and type 2 diabetes an...

Tumor-selective E1a and E1b mutants

Enhanced adoptive cell therapy

Tropism modified cancer terminator virus (Ad.5/3 CTV;Ad.5/3-CTV-M7)

Activation of resident memory T cells for cancer immunotherapy

Enhanced adoptive cell therapy

Methods and compositions for modulating AAV infection

Multitargeting onocolytic adenovirus, methods of use, and methods o...

AAV vectors with expanded packaging capacity

MiR-204 and miR-211 and uses thereof

Patents Applicationslast 30 patents

METHOD FOR TREATING TUMOR WITH COMBINATION OF EXOGENOUS ANTIGEN AND...

SELECTIVE STIMULATION OF T CELLS IN SOLID TUMORS USING ONCOLYTIC VI...

IMMUNOEVASIVE ANTI-TUMOR ADENOVIRUS

THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR BONE AND SOFT TISSUE TUMORS

GROUP B ADENOVIRUS ENCODING AN ANTI-TCR-COMPLEX ANTIBODY OR FRAGMENT

ADENOVIRUS FOR TREATMENT OF CANCER

CHIMERIC BROAD-SPECTRUM ONCOLYTIC ADENOVIRUS WITH MULTIPLE MECHANIS...

Oncolytic Virus and Methods of Use

An oncolytic virus vector coding for variant interleukin-2 (vIL-2)...

RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATE...

RECOMBINANT ADENOVIRUS GENOME HAVING A SYNTHETIC TRANSCRIPTIONAL UN...

METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY

THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CEL...

METHODS OF TREATING BLADDER CANCER

Fast and Accurate Three-Plasmid Oncolytic Adenovirus Recombinant Pa...

VECTORIZED ANTIBODIES AND USES THEREOF

ONCOLYTIC ADENOVIRUS COMPOSITIONS

PH-SENSITIVE AND BIOREDUCIBLE POLYMER-VIRUS COMPLEX FOR CANCER TREA...

DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES

COMPOSITION COMPRISING NC886 FOR IMPROVING ONCOLYTIC VIRUS ACTIVITY...

ONCOLYTIC VIRUS EXPRESSING PD-1 BINDING PROTEIN AND APPLICATION OF...

NOVEL AAV8 MUTANT CAPSIDS AND COMPOSITIONS CONTAINING SAME

TUMOR-SELECTIVE E1A AND E1B MUTANTS

REPLICATION-ENHANCED ONCOLYTIC ADENOVIRUSES

TROPISM MODIFIED CANCER TERMINATOR VIRUS (AD.5/3 CTV;AD.5/3-CTV-M7)

Enhanced adoptive cell therapy

Isolated Recombinant Oncolytic Adenoviruses, Pharmaceutical Composi...

Tissue Targeted Antigenic Activation of the Immune Response to Trea...

METHOD FOR REMOVING ANTI-AAV ANTIBODIES FROM A BLOOD-DERIVED COMPOS...

ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING...